Monday, February 25, 2013- Why Dynavax Technologies Shares Implodedat Motley Fool (Mon, Feb 25)
- [$$] Dynavax Vaccine Needs Further Evaluationat The Wall Street Journal (Mon, Feb 25)
- What's Next for Dynavax?at Motley Fool (Mon, Feb 25)
- Dynavax Technologies Corporation - Special Callat Seeking Alpha (Mon, Feb 25)
- Monday Sector Laggards: Education & Training Services, Biotechnology Stocksat Forbes (Mon, Feb 25)
- Dynavax tumbles as FDA asks for more Heplisav dataAP (Mon, Feb 25)
- Buy, Sell, or Hold: Vicalat Motley Fool (Mon, Feb 25)
- US STOCKS-Wall St rallies on growth optimismat Reuters (Mon, Feb 25)
- Stock Futures Point to Higher Openat TheStreet (Mon, Feb 25)
- US STOCKS-Futures point to higher open, Barnes & Noble ralliesat Reuters (Mon, Feb 25)
- BRIEF-Dynavax Technologies shares off 28 pct premarketat Reuters (Mon, Feb 25)
- Dynavax May Seek Quick Re-File of HepB Vax Following FDA Rejectionat TheStreet (Mon, Feb 25)
- UPDATE 1-FDA rejects Dynavax's adult hep B vaccine on safety concernsat Reuters (Mon, Feb 25)
- FDA rejects Dynavax's adult hep B vaccine on safety concernsat Reuters (Mon, Feb 25)
- Dynavax Receives FDA Complete Response Letter on HEPLISAV(TM) Biologic License ApplicationMarketwired (Mon, Feb 25)
- Dynavax Technologies downgraded by MLV & CoBriefing.com (Mon, Feb 25)
Thursday, February 21, 2013 Sunday, February 17, 2013 Thursday, February 14, 2013 Wednesday, February 13, 2013 Tuesday, February 12, 2013 Monday, February 11, 2013 Friday, February 8, 2013Add DVAX News to My Yahoo!  | |
|